Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Relapsing-Remitting Multiple Sclerosis
NCT00035529Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2001
- Primary completion
- Dec 2003
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in relapsing-remitting multiple sclerosis (RRMS), sponsored by Bristol Myers Squibb. Started Nov 2001; status: terminated.
02
Drugs
abatacept
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00035529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035529.